Estimates Revisions CVS Group plc OTC Markets
Stocks
CVSGF
GB00B2863827
Healthcare Facilities & Services
|
Market Closed -
OTC Markets
09:30:02 2026-08-11 EDT
|
5-day change | 1st Jan Change | ||
| 16.60 USD | +0.42% |
|
-.--% | +2.34% |
| 09-24 | DIRECTORS DEALINGS: Oxford BioMedica chair buys 20,250 shares | AN |
| 09-24 | CVS Group plc acquired 75% stake in Baulkham Hills Glass Pty. Ltd. for for £21.2 million. | CI |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Data source:
CVS Group plc(CVSG)
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Data source:
CVS Group plc(CVSG)
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
Data source:
CVS Group plc(CVSG)
EBIT
Dividend / Share (DPS)
Data source:
CVS Group plc(CVSG)
Cash or Net Debt
- Stock Market
- Stocks
- CVSG Stock
- CVSGF Stock
- Consensus CVS Group plc
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
